Dr. Fischer studies tissues from unique mouse models to elucidate the phenotypic progression involved in tumor formation. He received his Ph.D. in molecular genetics from the University of Cincinnati. Dr. Fischer is currently leading a research team at Oregon Health and Science University in partnership with Eternans to test the effects of Eternan’s senolytic agents on cancer in vivo.
